Wells Fargo
GTHX

Wells Fargo’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-28,118
Closed -$64.1K 6611
2024
Q2
$64.1K Sell
28,118
-2,947
-9% -$6.72K ﹤0.01% 4826
2024
Q1
$134K Buy
31,065
+8,507
+38% +$36.8K ﹤0.01% 4353
2023
Q4
$68.8K Buy
22,558
+1,317
+6% +$4.02K ﹤0.01% 4718
2023
Q3
$30.6K Sell
21,241
-9,392
-31% -$13.5K ﹤0.01% 5066
2023
Q2
$76.3K Buy
30,633
+2,794
+10% +$6.96K ﹤0.01% 4930
2023
Q1
$74.6K Buy
27,839
+2,347
+9% +$6.29K ﹤0.01% 4678
2022
Q4
$138K Sell
25,492
-28,869
-53% -$157K ﹤0.01% 4089
2022
Q3
$680K Buy
54,361
+22,606
+71% +$283K ﹤0.01% 3275
2022
Q2
$157K Sell
31,755
-13,383
-30% -$66.2K ﹤0.01% 4160
2022
Q1
$343K Sell
45,138
-12,349
-21% -$93.8K ﹤0.01% 4382
2021
Q4
$587K Sell
57,487
-48,918
-46% -$500K ﹤0.01% 4242
2021
Q3
$1.43M Buy
106,405
+9,606
+10% +$129K ﹤0.01% 3739
2021
Q2
$2.12M Buy
96,799
+18,102
+23% +$397K ﹤0.01% 3468
2021
Q1
$1.89M Buy
78,697
+36,544
+87% +$880K ﹤0.01% 3532
2020
Q4
$758K Buy
42,153
+11,952
+40% +$215K ﹤0.01% 4152
2020
Q3
$349K Buy
30,201
+2,554
+9% +$29.5K ﹤0.01% 4486
2020
Q2
$671K Buy
27,647
+8,081
+41% +$196K ﹤0.01% 4010
2020
Q1
$216K Buy
19,566
+549
+3% +$6.06K ﹤0.01% 4472
2019
Q4
$502K Sell
19,017
-956
-5% -$25.2K ﹤0.01% 4266
2019
Q3
$455K Buy
19,973
+6,337
+46% +$144K ﹤0.01% 4328
2019
Q2
$418K Sell
13,636
-1,489
-10% -$45.6K ﹤0.01% 4382
2019
Q1
$251K Sell
15,125
-11
-0.1% -$183 ﹤0.01% 4638
2018
Q4
$290K Buy
15,136
+4,827
+47% +$92.5K ﹤0.01% 4531
2018
Q3
$539K Buy
10,309
+675
+7% +$35.3K ﹤0.01% 4291
2018
Q2
$419K Buy
9,634
+4,080
+73% +$177K ﹤0.01% 4477
2018
Q1
$206K Buy
5,554
+899
+19% +$33.3K ﹤0.01% 4787
2017
Q4
$92K Buy
4,655
+4,107
+749% +$81.2K ﹤0.01% 5116
2017
Q3
$14K Buy
+548
New +$14K ﹤0.01% 5454